Short Communication - (2013) Volume 4, Issue 6

The Effect of Imatinib Treatment Duration on the Quality of the Life of Patients with Chronic Myeloid Leukemia

Katerina Skrivanova1*, Marcela Bendova1, Ladislav Dusek2, Daniela Zackova3, Zdenek Racil3 and Jiri Mayer3,4
1Department of Psychology and Psychosomatics, Faculty of Medicine, Kamenice 3, 625 00, Masaryk University, Brno, Czech Republic
2Institute of Biostatistics and Analyses Masaryk University, Brno, Czech Republic
3Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
4Central European Institute of Technology (CEITEC), Brno, Czech Republic
*Corresponding Author: